Notícias e Atividades da Cure Pharmaceutical
Presença
Cure Pharmaceutical é uma empresa listada sob o símbolo CURR (US).
Executivos
Veja o organograma con seus 8 executivos principais
Biografias mais buscadas da Cure Pharmaceutical
- Robert Davidson, Chief Executive Officer and Chairman of the Board
- Mike Valentino, Chairman of the Board
- Alan Preston, Director
Criar um alerta
para seguir os movimentos de executivos da Cure Pharmaceutical.
Farmacêutica
Cure Pharmaceutical possui 1.833 concorrentes concorrentes Pfizer (Estados Unidos), Sanofi (França) e Eli Lilly (Estados Unidos).
Popular M&A news in Farmacêutica
- Imbria Pharmaceuticals acaba de anunciar uma arrecadação de fundos de 58 milhões de dólares. (publicado em 10 de abril de 2025).
- Clario adquiriu NRx Pharmaceuticals (publicado em 18 de março de 2025).
- Knight Therapeutics has announced the acquisition of Paladin Labs (publicado em 12 de março de 2025).
Outros contatos sugeridos na indústria do Farmacêutica
Notícias
Últimos comunicados de imprensa de Cure Pharmaceutical
- CURE Pharmaceutical Letter to Shareholders - CURE Pharmaceutical
- CURE Pharmaceutical Reports Third Quarter 2022 Results With Strong Sequential and Year Over Year Revenue Increases and Continued High Margins - CURE Pharmaceutical
- Cure Pharmaceutical Holding to Present at the LD Micro Main Event XV - CURE Pharmaceutical
- Cure Pharmaceutical Reports Second Quarter 2022 Results With Increased Sequential Revenues and Strong Margins - CURE Pharmaceutical
- CURE Pharmaceutical Announces Rob Davidson as new Chairman of the Board and Appointment of Rob Costantino as Member of the Board and Audit Committee Chairman - CURE Pharmaceutical
- CURE Pharmaceutical Provided Full Corporate Update on Recent Shareholder Call - CURE Pharmaceutical
- CURE Pharmaceutical Announces the Appointment of New Board Member - CURE Pharmaceutical
- CURE Pharmaceutical Announces Teleconference With Investors - CURE Pharmaceutical
- CURE Pharmaceutical Announces the Sale of a Portion of its Platform Technology IP for $20 Million - CURE Pharmaceutical
- CURE Pharmaceutical Announces Positive Findings from Study at Cincinnati Children's Hospital Medical Center (CCHMC) Using CURE's Proprietary, Oral Thin Film (OTF) High, Single Dose Vitamin D in Pediatric Patients Pre- and Post-Hematopoietic Stem Cell Tran
- View more press releases Close
Redes sociais sobre Cure Pharmaceutical
- Cure Pharmaceutical na Wikipedia, Google News e Yahoo Finance
- Cure Pharmaceutical na LinkedIn, Twitter e YouTube
